These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30070318)
1. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma. Li YC; Wang D; Zhu GY Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. Zhou T; Gao Y World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762 [TBL] [Abstract][Full Text] [Related]
6. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898 [TBL] [Abstract][Full Text] [Related]
9. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma. Tian F; Xu J; Xue F; Guan E; Xu X Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230 [TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma. Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma. Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071 [TBL] [Abstract][Full Text] [Related]
12. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964 [TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
17. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
18. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Tu ZQ; Li RJ; Mei JZ; Li XH Int J Clin Exp Pathol; 2014; 7(7):4303-9. PubMed ID: 25120813 [TBL] [Abstract][Full Text] [Related]
20. Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Huang R; Wang X; Zhang W; Zhangyuan G; Jin K; Yu W; Xie Y; Xu X; Wang H; Sun B Cell Physiol Biochem; 2016; 40(3-4):707-715. PubMed ID: 27898409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]